Connect with us

News

Medical Devices Market | COVID-19 Recovery Analysis, Drivers, Restraints, Opportunities and Threats | Technavio

gbafNews28

The medical devices market is poised to grow by $ 87.65 bn during 2020-2024 progressing at a CAGR of almost4% during the forecast period. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Download Free Sample Report on COVID-19 Recovery Analysis

The report on the medical devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of diseases.

The medical devices market analysis includes product, and geography landscape. This study identifies the emergence of innovative technologies as one of the prime reasons driving the medical devices market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters

The Medical Devices Market covers the following areas:

Medical Devices Market Sizing

Medical Devices Market Forecast

Medical Devices Market Analysis

Companies Mentioned

  • Becton, Dickinson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • General Electric Co.
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic Plc
  • Olympus Corp.
  • Siemens AG
  • Stryker Corp.

Key Topics Covered:

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 – 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product placement
  • Therapeutic and surgical devices – Market size and forecast 2019-2024
  • PMDMID – Market size and forecast 2019-2024
  • Other medical devices – Market size and forecast 2019-2024
  • Market opportunity by Product

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • Asia – Market size and forecast 2019-2024
  • ROW – Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver – Demand led growth
  • Volume driver – Supply led growth
  • Volume driver – External factors
  • Volume driver – Demand shift in adjacent markets
  • Price driver – Inflation
  • Price driver – Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Becton, Dickinson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • General Electric Co.
  • Johnson and Johnson Services Inc.
  • Koninklijke Philips NV
  • Medtronic Plc
  • Olympus Corp.
  • Siemens AG
  • Stryker Corp.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]

Website: www.technavio.com/

News

Biodesix Publishes Extended Analyses of the Nodify XL2® Lung Nodule Test

gbafNews28

Biodesix, Inc. (Nasdaq: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced publication of an analysis of the companys Nodify XL2 lung nodule test. The test supports clinical decision-making for suspicious nodules by more accurately identifying patients with a very low risk of malignancy and shifting those patients into surveillance, thereby minimizing invasive procedures on those with benign nodules.

In previously published findings from the Pulmonary Nodule Plasma Proteomic Classifier (PANOPTIC) Trial, the Nodify XL2 test was shown to accurately identify patients with lung nodules who have a pre-test risk of malignancy less than 50% as likely benign. After one year of follow-up, the test demonstrated a sensitivity of 97%, specificity of 44%, and negative predictive value of 98%, which is more accurate than other commonly used lung nodule risk assessment calculators.

The new paper, published in the American College of Chest Physicians (CHEST) Journal, presents findings that all nodules in the study group that were established as benign after one year remained benign after two years of follow-up. This data confirms the performance of the Nodify XL2 test over the guideline-recommended two-year surveillance period to radiologically confirm a benign diagnosis. Additionally, a new analysis suggests that the classifier performs similarly regardless of the whether the nodule of concern was solitary or there were other nodules present.

This assessment demonstrates our commitment to providing long-term follow-up for patients and to continuously study the performance of our tests, said Scott Hutton, CEO of Biodesix. Central to our mission is the drive to improve patient outcomes while reducing ineffective and unnecessary treatments and procedures. Nodify XL2 exemplifies this. With this test, part of our Nodify LungTM testing strategy, physicians are equipped with vital and time-sensitive information to help efficiently determine the appropriate course of treatment for each patient.

About Nodify XL2 Lung Nodule Test

The Nodify XL2 blood-based proteomic test helps identify patients who have a suspicious lung nodule that is likely benign or at a reduced risk of being cancerous. Results help physicians to identify patients who may be better candidates for routine CT surveillance to monitor for growth or shrinkage of the nodule over time instead of an invasive diagnostic procedure. The Nodify XL2 test is used for patients who are 40 years or older, have nodules between 8mm and 30mm, and have a pre-test risk of lung cancer of less than or equal to 50%.

The test is performed in Biodesixs COLA-accredited laboratory in De Soto, Kansas.

About Biodesix

Biodesix is a leading diagnostic company with a focus in lung disease. The Company develops diagnostic tests addressing important clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix is the first company to offer six non-invasive tests for patients with diseases of the lung. Biodesix launched the SARS-CoV-2 ddPCR„¢ test and the Platelia SARS-CoV-2 Total Ab in response to the global pandemic and virus that impacts the lung and causes COVID-19. The blood-based Biodesix Lung Reflex strategy for lung cancer patients integrates the GeneStrat and VeriStrat tests to support treatment decisions with results in 72 hours, expediting time to treatment. The blood-based Nodify Lung„¢ nodule risk assessment testing strategy, consisting of the Nodify XL2 and the Nodify CDT„¢ tests, evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the most appropriate course of action. Biodesix also collaborates with many of the worlds leading biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease. For more information about Biodesix, visit biodesix.com.

Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements contained in this press release other than statements of historical fact, are forward-looking statements. The words believe, may, will, estimate, continue, anticipate, intend, plan, expect, predict, potential, opportunity, goals, or should, and similar expressions are intended to identify forward-looking statements. Such statements are based on managements current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors. Biodesix has based these forward-looking statements largely on its current expectations and projections about future events and trends. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. Moreover, Biodesix operates in a competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for its management to predict all risks, nor can it assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements it may make. Biodesix undertakes no obligation to revise or publicly release the results of any revision to such forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.

Jordona Jackson Smith

[email protected]

805-674-7347

Continue Reading

News

Kount Partners With Snowflake to Deliver Actionable Customer Insights for eCommerce Providers to Improve Customer Experience, Lower Friction, Increase Conversions and Uncover Cross-sell and Upsell Opportunities

gbafNews28

Kount, the leader in identity trust and digital fraud protection, today announced a partnership with Snowflake, provider of Data Cloud, to offer actionable customer insights via Snowflake Data Marketplace. This new product, called Data on Demand, is the industrys first private data warehouse enriched with insights from Kounts Identity Trust Global Network, powered by advanced artificial intelligence and machine learning.

Hosted by Kount and fueled by Snowflake, Data on Demand gives enterprises the unprecedented ability to proactively employ data to increase revenue opportunities via customized upsell, cross-sell and downsell initiatives. Businesses can use Data on Demand to reduce friction, discover omnichannel customer behavior and evaluate fraud prevention initiatives.

In todays digital world, data is key to success. Data on Demand empowers businesses to easily combine all their company data with additional insights to gain deep analysis, access personalized reporting and create custom machine learning models.

Besides device, location and decision data, insights in Data on Demand can include:

  • Customer-collected payment details
  • Data from Kounts user-defined fields
  • Data from triggered rules, reviews and outcomes

Kounts Data on Demand is built on Snowflake. Snowflakes platform requires near-zero maintenance and separates compute from storage to enable businesses to quickly manipulate high volumes of data in the cloud with near-zero performance, concurrency or scale limitations. Snowflake Data Marketplace uses secure data sharing technology to provide a single source of truth for data from across an organization’s ecosystem, which can be combined with additional data sources for even deeper insights.

Kounts Data on Demand and Identity Trust Global Network leverage Snowflakes Data Marketplace to share data from across sources in a secure and governed way, said Matt Glickman, Snowflake VP of Customer Product Strategy, Data Marketplace. This partnership gives our joint customers the ability to more fully utilize their data to gain a deeper understanding of customer behavior, support fraud prevention and provide meaningful business value.

Snowflake and Kounts new partnership is a game changer in understanding true omnichannel customer behavior, as well as discovering new segmentation, cross-sell and upsell and customer retention strategies, said Gary Sevounts, Kount CMO. With unprecedented growth in digital commerce comes unprecedented opportunity to uncover new customer journey paths, reduce friction and take customer experiences to the next level. Data on Demand is the key to unlocking huge amounts of both new and existing data from many sources.

To learn more about Data on Demand, click here. Snowflake and Kount will share specific examples and uses of Data on Demand in an upcoming free webinar on December 15. Register here.

About Kount

Kounts Identity Trust Global Network delivers real-time fraud prevention and account protection and enables personalized customer experiences for more than 9,000 leading brands and payment providers. Linked by Kounts award-winning AI, the Identity Trust Global Network analyzes signals from 32 billion annual interactions to personalize user experiences across the spectrum of trustfrom frictionless experiences to blocking fraud. Quick and accurate identity trust decisions deliver safe payment, account creation and login events while reducing digital fraud, chargebacks, false positives and manual reviews. Kount.com

Lacey Briggs

Public Relations Manager

[email protected]

[email protected]

208-489-3334

Continue Reading

News

BlackRock Unveils New Offering to Power Investors’ Transition to Net Zero Emissions

gbafNews28

Building on BlackRocks strength in risk management through the Aladdin platform, BlackRock today announced it has created Aladdin Climate to meet the urgent need among financial institutions and investors to quantify climate risk in their portfolios as the physical toll of climate change mounts and the global transition to net zero emissions accelerates.

Aladdin Climate is the first software application to offer investors measures of both the physical risk of climate change and the transition risk to a low-carbon economy on portfolios with climate-adjusted security valuations and risk metrics. Using Aladdin Climate, investors can now analyze climate risk and opportunities at the security level and measure the impact of policy changes, technology, and energy supply on specific investments. Aladdin Climate is initially available as an add-on for existing Aladdin clients globally with asset class coverage rolled out gradually over the course of 2021.

There is no single issue that clients ask us more about than the impact of climate risk on their portfolio, said Rob Goldstein, BlackRocks Chief Operating Officer. Yet, while lots of people are talking about climate risk today, what investors need to make informed decisions is data tied to specific securities in their portfolio. Aladdin Climate is a dramatic step forward to begin filling the information gap necessary to build truly sustainable portfolios.

Evolution of ESG Data

Investors have long highlighted the need for improved ESG data to increase sustainable investing strategies. Now, the dramatic growth in relevant corporate disclosures and unstructured data has created unprecedented opportunities to enhance climate analytics. Today, more than 85% of S&P 500 companies disclose ESG data, compared to 20% ten years ago and Sustainability Accounting Standards Boards (SASB) disclosures have increased 288% since January.

More and more organizations seek to report on climate risk, whether for mandatory stress tests or voluntary disclosures such as the Task Force on Climate-related Financial Disclosures (TCFD) recommendations, but have lacked tools that quantify climate risk. Aladdin Climate will help clients stress test investments to estimate how they might perform in different climate scenarios like those outlined in the Paris Agreement.

We are building on BlackRocks strength in financial modeling and risk management to set a standard for climate risk analytics, said Mary-Catherine Lader, Head of Aladdin Sustainability at BlackRock. Aladdin Climate analyzes climate risk alongside traditional risk metrics for a holistic view of risk across the investment process, all integrated in existing Aladdin workflows. Investors can now analyze tough questions about rising sea levels potential impact on their portfolios, or how a rapid shift to low-carbon policies could affect specific companies.

Partnerships with Sustainalytics and Refinitiv

BlackRock has also expanded access to ESG data through new partnerships with leading data providers Sustainalytics and Refinitiv. Aladdin now offers over 1,200 key performance indicators to help portfolio and risk managers identify sustainability-related risks in their exposures and make informed asset allocation decisions. By providing all Aladdin clients a set of ESG scores across a broad universe of companies, BlackRock is making it easier for investors to incorporate ESG metrics in their investment process.

About Aladdin Aladdin is BlackRocks end-to-end investment management and operations platform used by institutional investors including asset managers, pension funds, insurers and corporate treasurers. It combines sophisticated risk analytics with comprehensive portfolio management, trading and operations tools on a single, unified platform. Also customized for wealth managers, Aladdin provides a common language across the investment lifecycle and enables a culture of risk transparency among users.

Logan Koffler

[email protected]

646.231.1904

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gbafNews28 gbafNews28
News46 mins ago

Centripetal Ranked Number 124 of the Fastest Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™

Centripetal today announced it ranked 124th on Deloittes Technology Fast 500„¢, a ranking of the 500 fastest growing technology, media,...

gbafNews28 gbafNews28
News46 mins ago

Viseon MaxView™ System Accelerates Adoption of Minimally Invasive Spine Surgery Procedures

Viseon, Inc., a leader in minimally invasive spine surgery visualization technologies, today announced MaxView„¢ facilitates more rapid adoption of Minimally...

gbafNews28 gbafNews28
News46 mins ago

BlackRock Unveils New Offering to Power Investors’ Transition to Net Zero Emissions

Building on BlackRocks strength in risk management through the Aladdin platform, BlackRock today announced it has created Aladdin Climate to...

gbafNews28 gbafNews28
News46 mins ago

Kount Partners With Snowflake to Deliver Actionable Customer Insights for eCommerce Providers to Improve Customer Experience, Lower Friction, Increase Conversions and Uncover Cross-sell and Upsell Opportunities

Kount, the leader in identity trust and digital fraud protection, today announced a partnership with Snowflake, provider of Data Cloud,...

gbafNews28 gbafNews28
News46 mins ago

Biodesix Publishes Extended Analyses of the Nodify XL2® Lung Nodule Test

Biodesix, Inc. (Nasdaq: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced publication of...

gbafNews28 gbafNews28
News46 mins ago

HSBC USA Observes #GivingTuesday with $400,000 In New Contributions to Feeding America, American Red Cross and to Address Evictions Crisis

HSBC Bank USA kicks off the year-end giving season with announcements on Giving Tuesday of increased contributions to organizations providing...

gbafNews28 gbafNews28
News46 mins ago

NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the development...

gbafNews28 gbafNews28
News46 mins ago

Pacific Premier Bank Makes $200,000 Grant to Susan G. Komen’s Patient Navigation Initiative for Breast Health in Orange County

Pacific Premier Bancorp, Inc. (NASDAQ: PPBI), the holding company of Pacific Premier Bank (the Bank), announced today the Bank has...

gbafNews28 gbafNews28
News46 mins ago

H.I.G. Growth Partners Completes Strategic Transaction with The Center for Digestive Health and Pinnacle GI Partners

H.I.G. Growth Partners (“H.I.G.”), the dedicated growth capital investment affiliate of H.I.G. Capital, is pleased to announce that one of...

gbafNews28 gbafNews28
News46 mins ago

DataTribe Announces Third Annual Cybersecurity Start-Up Challenge Finalists

DataTribe, a global cyber foundry that invests in and co-builds next-generation cybersecurity and data science companies, announced today the finalists...